At a glance
ClinicalIndex Comparison RecordN/ACompleted· 298 enrolled
Drug / intervention
Bioimpedance Spectroscopy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Post-dialysis Weight Evaluated With Bioimpedance Spectroscopy on Dialysis Morbidities and Clinical Outcomes in Hemodialysis Patients: A Randomized Controlled Trial
In Brief
A clinical study evaluating Bioimpedance Spectroscopy and Clinical judgement for Fluid Overload. Completed, enrolled 298 participants.
Detailed Summary
A reasonable and simple algorithm was used to guide the dry weight determination with Body Composition Monitor with the principle of Bioimpedance Spectroscopy (BCM-BIS) and analyze the feasibility of this algorithm and evaluate the influence of BCM-BIS-guided fluid management on the incidence of dialysis morbidities and clinical outcomes in maintenance hemodialysis (MHD) patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFluid Overload
Countries--
CollaboratorsNephrocare AsiaPacific
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
Primary CompletionOct 2014
First PostedDec 2014
TodayJul 2026
First PostedDec 25, 2014
Enrollment StartOct 1, 2013
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.5 years ago
Interventions
Bioimpedance Spectroscopydevice
Bioimpedance Spectroscopy is a safe tool to evaluate the fluid status in hemodialysis patients.
Clinical judgementbehavioral